ArticleCureus2025
From Years of Pain to a Name: Fibromyalgia Uncovered.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibromyalgia is a chronic multisystem disorder marked by widespread pain, fatigue, and sleep and mood disturbances, predominantly affecting women. Its multifactorial etiology and diagnosis by exclusion often delay recognition. A multimodal approach, with reassurance, shared treatment goals, education, cognitive behavioral therapy (CBT), and exercise, is critical. Effective pharmacologic options include duloxetine, milnacipran, pregabalin, and amitriptyline. This report describes a female in her late thirties who presented to the clinic with chronic widespread pain. Her past medical history was significant for a motor-vehicle accident four months ago, bipolar II disorder, major depressive disorder, post-traumatic stress disorder, irritable bowel syndrome, cardiomyopathy, stage 3 chronic kidney disease, hidradenitis suppurativa, and melanoma. When repeated laboratory tests and imaging failed to provide answers, it became increasingly clear that this patient's case was particularly challenging to diagnose, especially due to existing comorbidities. However, after ruling out the common causes for diffuse chronic pain, fibromyalgia was diagnosed. This case illuminates the importance of clinicians being patient advocates throughout the journey and listening attentively to patients' concerns even when laboratory results and imaging appear unremarkable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.